Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21578,772,1.12 [0.95-1.32],0.164924970871808
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21572,121,1.34 [0.95-1.88],0.0925355595809988
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22941,126,1.02 [0.66-1.57],0.9267060842402828
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17088,430,1.37 [1.14-1.65],0.0007451964600622
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22890,75,1.18 [0.73-1.93],0.4990435320217741
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22261,68,1.22 [0.75-1.98],0.4304372644718081
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23755,74,1.20 [0.75-1.94],0.4477700597090616
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23775,49,0.95 [0.45-2.02],0.8931491692446193
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21784,39,1.09 [0.51-2.34],0.8173336173836178
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23330,93,1.13 [0.72-1.79],0.5951208121102484
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23295,58,1.23 [0.73-2.07],0.4439911120166363
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23814,57,0.90 [0.44-1.84],0.7677681927437818
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23774,91,1.50 [1.12-2.02],0.0068734222879747
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23766,83,1.54 [1.15-2.07],0.0042379321397709
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Mycoses,23613,44,1.21 [0.66-2.23],0.5424933845600965
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23052,327,1.07 [0.82-1.39],0.6259595396566403
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22843,118,1.20 [0.82-1.75],0.3395167349525966
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22938,213,0.92 [0.63-1.33],0.6515908451532677
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20632,26,1.43 [0.76-2.67],0.2642514442476209
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20649,43,1.06 [0.54-2.09],0.867647162472511
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20717,111,1.27 [0.90-1.81],0.1784718145827685
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20722,116,1.26 [0.89-1.79],0.1835223391797513
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11593,255,1.29 [1.04-1.62],0.0232217675123972
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9288,20,1.00 [0.31-3.20],0.996092759927074
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20648,42,1.06 [0.52-2.16],0.8626139757345359
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22010,695,1.23 [1.05-1.44],0.0093299380108098
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22920,182,1.19 [0.87-1.62],0.2829032097023713
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23453,72,1.20 [0.74-1.96],0.4557960328397744
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23877,70,1.02 [0.57-1.84],0.9488182881192369
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Rectum,23682,41,1.33 [0.74-2.38],0.342523533759252
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23882,35,0.48 [0.13-1.69],0.251351133741202
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Stomach,23916,28,0.54 [0.14-2.09],0.372798404520033
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm,23653,261,1.03 [0.76-1.39],0.8456890889449213
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23859,105,0.95 [0.57-1.57],0.8279898266847341
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23861,79,1.11 [0.66-1.85],0.7016993585339293
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23833,40,1.37 [0.79-2.37],0.2664496141502148
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma, any site",23835,40,1.37 [0.79-2.37],0.2664960767564065
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi,23736,211,0.99 [0.71-1.38],0.9501294348569754
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23881,96,1.08 [0.69-1.69],0.7439694565728926
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Other benign neoplasms of skin,23796,161,0.78 [0.49-1.25],0.308520131199519
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of breast,13188,80,1.40 [0.98-1.99],0.0642207983406743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Leiomyoma of uterus,12897,596,1.14 [0.96-1.37],0.1364949547045578
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23069,160,0.99 [0.67-1.47],0.9702805619831668
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22965,296,1.21 [0.96-1.53],0.1045015575555408
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22965,296,1.21 [0.96-1.53],0.1045015575555408
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21892,302,1.22 [0.97-1.55],0.0922213298994134
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23485,72,1.14 [0.69-1.88],0.616117296736998
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23697,89,1.69 [1.30-2.20],8.999463134779515e-05
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,20960,610,1.23 [1.03-1.46],0.022392068320286
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22812,370,1.31 [1.08-1.59],0.0053267893664059
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22346,89,1.44 [1.01-2.06],0.0435336022491126
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23252,49,1.25 [0.67-2.33],0.4821768110565088
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22334,77,1.54 [1.08-2.18],0.0159203368289589
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22534,277,1.18 [0.89-1.57],0.2492306363155081
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22527,270,1.20 [0.91-1.59],0.2028866320539465
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22235,151,1.17 [0.75-1.82],0.4903002160115469
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22238,148,1.21 [0.78-1.86],0.3933817648511661
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20820,470,1.08 [0.86-1.36],0.503360342855822
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20415,65,1.05 [0.57-1.96],0.8656429082281933
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,20782,432,1.08 [0.85-1.36],0.549920695588106
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20391,41,1.48 [0.90-2.42],0.1242441280275193
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20411,61,1.55 [1.05-2.27],0.0259820397213473
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Any mental disorder,20718,651,1.21 [1.01-1.44],0.0354529544964542
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20324,257,0.94 [0.65-1.34],0.7195380759642713
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23543,194,1.06 [0.73-1.53],0.758861602693508
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23600,141,1.17 [0.78-1.73],0.4493961176106797
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22205,70,0.98 [0.53-1.82],0.9462557873036982
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23818,70,0.97 [0.52-1.82],0.9263965632203136
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20137,70,0.99 [0.53-1.86],0.9870893279377264
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Alcohol dependence,22219,84,1.23 [0.76-1.98],0.3930844779143134
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Smoking dependency,22173,61,0.98 [0.49-1.97],0.9500237208923832
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20136,69,1.16 [0.68-1.98],0.5762247193895158
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20389,322,1.21 [0.96-1.53],0.109258975904535
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Depression,22409,278,1.22 [0.95-1.56],0.1261372673372363
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Depression or dysthymia,20264,243,1.18 [0.90-1.56],0.2291615617657368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20188,121,1.10 [0.73-1.66],0.6445213562529559
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Other anxiety disorders,22626,57,1.01 [0.52-1.97],0.9686150859948672
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Neurological diseases,21290,1261,1.07 [0.94-1.23],0.3137044889568116
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19837,155,1.37 [1.04-1.81],0.025755476981862
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23729,126,1.24 [0.88-1.74],0.2295000237149544
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22774,425,1.07 [0.85-1.35],0.5431665283999465
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Epilepsy,22496,147,1.25 [0.91-1.73],0.172435164069809
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Migraine,22435,86,1.01 [0.60-1.70],0.981514789245068
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23595,76,1.13 [0.69-1.85],0.6170705285975784
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23492,35,1.14 [0.54-2.40],0.7317075553737168
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other sleep disorders,22498,149,0.82 [0.50-1.34],0.4284828239843418
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Sleep apnoea,23388,114,0.72 [0.39-1.33],0.3010261366311458
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22933,527,0.79 [0.61-1.03],0.0783385945975317
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22527,121,0.83 [0.50-1.39],0.4778537205421297
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22687,281,0.81 [0.57-1.16],0.2541101915975354
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23732,74,1.18 [0.73-1.90],0.5005216989904915
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hemiplegia,23706,48,1.22 [0.69-2.14],0.4917013638626771
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other neurological diseases,23545,105,1.38 [1.00-1.92],0.051403843264084
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23509,277,1.04 [0.78-1.38],0.8045131269420422
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23381,149,0.83 [0.52-1.33],0.4406604982905037
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23309,77,1.11 [0.68-1.82],0.6758442086588532
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23321,89,0.85 [0.47-1.55],0.6029852784593088
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23276,44,1.54 [1.00-2.35],0.0489222113226318
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22433,53,0.71 [0.29-1.74],0.4565881051933552
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22540,160,0.78 [0.48-1.26],0.3074769843310849
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23383,109,0.70 [0.38-1.30],0.2594856454765792
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23698,18,0.94 [0.26-3.36],0.9244164936028054
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1509,18,0.61 [0.14-2.62],0.5092193687000561
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22207,18,0.96 [0.27-3.36],0.9471310586805152
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23589,43,1.69 [1.12-2.55],0.0132166751111372
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23569,23,1.51 [0.79-2.91],0.2127831297918773
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23505,84,0.94 [0.54-1.65],0.8356158841157185
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23559,86,0.61 [0.29-1.29],0.1955820192793643
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23805,109,1.02 [0.63-1.64],0.938191451806594
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23464,84,1.15 [0.73-1.82],0.5393205413642961
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18672,1700,1.18 [1.05-1.33],0.005235098473744
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23641,36,1.14 [0.55-2.35],0.7240823067098663
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19594,1134,1.21 [1.05-1.39],0.0068265243593832
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertension,19611,1151,1.21 [1.06-1.39],0.0061546487006812
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18492,32,1.77 [1.22-2.56],0.0025914041416734
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22615,495,1.23 [1.01-1.50],0.0353169456355636
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Angina pectoris,22419,299,1.09 [0.82-1.45],0.5407916670573412
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23286,118,1.00 [0.62-1.61],0.9962842601162292
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23392,224,1.21 [0.91-1.61],0.1848211291339537
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23820,50,1.13 [0.60-2.15],0.7074672494269905
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22259,139,1.40 [1.04-1.90],0.0269443248203974
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22479,369,1.22 [0.96-1.53],0.0992904610087591
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23471,75,0.92 [0.50-1.71],0.7935578290516538
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23472,159,1.03 [0.70-1.52],0.8763360662415177
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23455,59,0.98 [0.50-1.91],0.9530216884822712
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23455,59,0.98 [0.50-1.91],0.9530216884822712
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18517,57,0.98 [0.50-1.90],0.9463717997454631
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21647,38,1.75 [1.17-2.60],0.0061749404633643
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,21673,64,1.10 [0.62-1.98],0.7393721925046078
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16274,81,1.21 [0.78-1.88],0.406457557521344
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16362,169,1.22 [0.89-1.68],0.2230484227759622
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arrhythmias,21645,36,0.83 [0.31-2.23],0.7101387874416678
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21660,51,0.58 [0.21-1.57],0.2832017046174669
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23488,106,1.37 [0.96-1.95],0.0809379273440059
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23450,96,0.96 [0.57-1.62],0.8744787392707741
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23480,73,0.65 [0.29-1.42],0.2775969270673999
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23520,63,0.50 [0.19-1.27],0.143870205769716
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23269,44,0.98 [0.44-2.19],0.9550122034777
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23299,74,1.44 [0.96-2.15],0.0750932105471983
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22871,105,1.03 [0.64-1.66],0.9044449326552672
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22854,88,1.17 [0.74-1.84],0.4972407643606255
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23778,85,1.22 [0.78-1.89],0.385739622022739
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Varicose veins,23140,374,1.14 [0.92-1.42],0.2379960264681514
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypotension,23288,43,1.21 [0.67-2.19],0.5198697382420642
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20236,1691,1.21 [1.08-1.34],0.0005869375986977
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23717,115,1.46 [1.10-1.93],0.0091366013571404
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22889,162,1.39 [1.06-1.81],0.0166342615231615
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22866,139,1.40 [1.06-1.86],0.0192249301827092
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23374,195,0.96 [0.66-1.40],0.8405380957526286
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23373,194,0.97 [0.66-1.41],0.8548893884040523
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23135,568,1.08 [0.89-1.32],0.415430979826916
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic sinusitis,22655,88,1.00 [0.60-1.69],0.9912849801631228
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Nasal polyp,22659,92,0.85 [0.48-1.53],0.5947789394718027
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22932,365,1.14 [0.91-1.43],0.2446840342316038
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Deviated nasal septum,22760,193,1.15 [0.85-1.55],0.3747379624465343
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13726,40,1.13 [0.57-2.24],0.7314216116946888
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21892,770,1.12 [0.95-1.32],0.1678924154563907
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Early onset COPD,23310,91,0.77 [0.39-1.52],0.4461709694814946
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23310,91,0.77 [0.39-1.52],0.4461709694814946
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23310,91,0.77 [0.39-1.52],0.4461709694814946
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22402,696,1.10 [0.93-1.31],0.2770304784163284
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Asthma,18261,696,1.11 [0.93-1.32],0.2485464837439164
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18135,696,1.11 [0.93-1.32],0.2537563876462466
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18248,683,1.11 [0.93-1.32],0.2610844571927687
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23751,56,2.09 [1.62-2.69],9.799220864587222e-09
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,22745,43,1.82 [1.28-2.60],0.0009291287547249
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23807,43,1.83 [1.28-2.61],0.0009690692125763
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22739,37,1.86 [1.28-2.71],0.0011139498615268
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural effusion,22743,70,0.97 [0.53-1.80],0.9338595483113769
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,22834,161,1.19 [0.86-1.66],0.2898890964495229
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23184,73,1.15 [0.70-1.91],0.5790685236162518
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16989,4444,1.11 [1.02-1.21],0.0124009588525276
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23395,424,1.16 [0.94-1.42],0.1573368451414443
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23853,119,1.00 [0.65-1.55],0.987965738231742
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impacted teeth,23858,110,1.04 [0.67-1.60],0.8752637797269274
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Dental caries,23077,106,1.28 [0.89-1.83],0.1877628583481144
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23070,99,1.11 [0.71-1.74],0.6406518720125474
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23840,134,1.01 [0.68-1.52],0.9445078747224448
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23046,75,1.02 [0.58-1.79],0.9412544043547948
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22839,56,1.08 [0.58-2.00],0.8075938975713017
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23815,41,1.37 [0.81-2.34],0.2437520927255742
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19242,178,1.02 [0.70-1.49],0.9175986578042172
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20594,1530,1.09 [0.96-1.23],0.1835581657866413
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophagitis,19296,232,1.12 [0.83-1.50],0.4736749567849561
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19550,486,1.14 [0.93-1.40],0.2112434868045632
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19124,60,0.94 [0.47-1.87],0.862228727227996
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19190,126,0.96 [0.60-1.53],0.855212422856397
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19089,25,1.46 [0.78-2.73],0.236054958692583
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastric ulcer,19152,88,0.91 [0.51-1.64],0.7614435028702404
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Duodenal ulcer,19155,91,1.24 [0.80-1.91],0.3401439978812369
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23827,65,1.15 [0.67-1.99],0.6186555454906992
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic gastritis,19161,97,0.91 [0.52-1.61],0.7521099774446286
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19626,562,1.12 [0.92-1.36],0.2649221463430116
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of appendix,23757,144,0.99 [0.66-1.50],0.9751241635363996
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,19400,336,1.17 [0.93-1.47],0.1921488955523307
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19164,100,1.17 [0.76-1.79],0.4703615802655042
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23745,165,1.22 [0.89-1.66],0.214823040007492
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute appendicitis,23726,113,0.85 [0.51-1.45],0.5593476603100489
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Hernia,21577,1017,1.07 [0.92-1.25],0.3704492636141085
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Inguinal hernia,20895,335,1.08 [0.84-1.39],0.531067918185242
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Umbilical hernia,20659,99,1.27 [0.85-1.89],0.2458803286085001
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ventral hernia,20636,76,0.85 [0.44-1.65],0.6367940470508806
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21093,533,1.03 [0.83-1.28],0.7965338747271236
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23162,649,1.09 [0.91-1.31],0.3253963492809137
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestines,19688,1437,1.11 [0.98-1.25],0.1008741715770516
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23634,62,1.38 [0.91-2.09],0.1285177120485831
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23845,88,1.23 [0.81-1.85],0.3257642623494223
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn disease,22601,88,1.23 [0.82-1.85],0.3241778395450284
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22580,67,1.33 [0.87-2.02],0.1917745708771799
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23796,108,1.16 [0.78-1.74],0.4579966475586993
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcerative colitis,22621,108,1.16 [0.78-1.74],0.4567029656257952
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22604,91,1.25 [0.84-1.86],0.2640416024791838
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23039,526,1.05 [0.86-1.30],0.6211442708798054
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23035,522,1.06 [0.86-1.30],0.611716649031204
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18311,60,0.60 [0.25-1.47],0.2636954427174991
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal stricture,23625,60,0.59 [0.24-1.45],0.2504945392099434
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18295,44,0.34 [0.10-1.17],0.0865401466770987
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18520,269,1.27 [1.00-1.62],0.0469779909964776
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18398,147,0.94 [0.62-1.44],0.7876073228567363
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18462,211,1.11 [0.82-1.51],0.4864421244036353
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Constipation,22926,190,1.14 [0.83-1.55],0.4228408487184725
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23548,75,0.87 [0.46-1.64],0.6651527365311656
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18406,155,1.20 [0.86-1.67],0.2742995455151467
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18331,80,0.82 [0.42-1.57],0.5437598571453681
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18938,687,1.10 [0.92-1.31],0.2861495159090329
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestine,18404,153,0.92 [0.59-1.41],0.6888683807975068
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23537,64,0.80 [0.39-1.66],0.5530063632699456
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of liver,23276,106,1.23 [0.83-1.83],0.295740019704964
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of liver,23231,61,1.29 [0.80-2.10],0.2944125606064448
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22825,439,1.30 [1.08-1.56],0.0060301609465878
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,22732,346,1.29 [1.05-1.60],0.0168556821163505
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholecystitis,22450,64,0.93 [0.48-1.82],0.8421096577091463
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22422,36,0.82 [0.32-2.12],0.6862611412271005
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis,22433,47,1.44 [0.89-2.33],0.1422359763566199
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23762,47,1.43 [0.88-2.33],0.1443107833641906
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22823,252,1.26 [0.98-1.62],0.0670923361730418
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22633,62,1.48 [1.00-2.20],0.0479255216596277
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Coeliac disease,22621,50,1.50 [0.98-2.31],0.0631349669588902
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22609,38,1.30 [0.72-2.34],0.3895248500582904
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22728,157,1.09 [0.75-1.58],0.6545500877819396
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,GI-bleeding,22723,152,1.11 [0.76-1.61],0.5917707875821967
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21699,1281,1.22 [1.08-1.38],0.0009801179282044
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23588,90,0.85 [0.46-1.55],0.5876207942800193
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23556,402,1.16 [0.94-1.43],0.1786680610228765
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22953,448,1.17 [0.96-1.43],0.1252251730318217
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23237,353,1.28 [1.04-1.57],0.0200730185249322
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22980,96,1.38 [0.98-1.95],0.0616076308392929
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23081,197,1.32 [1.01-1.72],0.0388669966475259
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23695,75,1.32 [0.87-2.01],0.1952669699565113
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23681,61,1.31 [0.82-2.09],0.2543912863099903
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23664,44,1.12 [0.58-2.17],0.7395883629343467
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23779,28,1.33 [0.68-2.57],0.4045022737245691
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23776,25,1.41 [0.74-2.67],0.2948058218589814
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23208,54,0.66 [0.27-1.63],0.3699653337637477
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23460,306,1.24 [0.99-1.55],0.0583883547611328
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22562,57,1.03 [0.55-1.95],0.9215311939084632
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22588,83,0.80 [0.42-1.52],0.4909331096987381
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22575,70,0.80 [0.40-1.62],0.5366536214362336
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22682,177,1.19 [0.87-1.62],0.2810510013194079
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22660,155,1.26 [0.93-1.72],0.1354538890523251
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18491,3028,1.09 [0.99-1.20],0.0737049099089814
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19866,1614,1.13 [1.00-1.27],0.0430213864855249
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21800,955,0.96 [0.81-1.14],0.6422591594037252
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18364,112,1.47 [1.10-1.95],0.0088610244298928
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18557,305,1.39 [1.14-1.69],0.0012806968056607
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23629,107,1.50 [1.12-2.02],0.0070269620455818
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23641,95,1.60 [1.20-2.13],0.0012494436440993
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18824,572,1.15 [0.95-1.38],0.1477169507879543
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",21040,572,1.16 [0.96-1.40],0.1131624832464799
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18292,40,1.07 [0.51-2.24],0.8537944890419309
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23589,39,1.12 [0.53-2.36],0.7637267687515297
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18381,129,1.17 [0.81-1.70],0.3986610163589938
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18275,23,1.70 [1.04-2.80],0.0349239678985909
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18361,109,1.34 [0.96-1.88],0.0869671534782103
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23812,58,1.15 [0.64-2.07],0.6505961096227053
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18540,288,0.85 [0.60-1.19],0.3328188518067489
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18442,190,1.30 [0.99-1.71],0.0629837876682508
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19320,1068,1.05 [0.91-1.22],0.5126936887279835
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18287,35,0.92 [0.38-2.21],0.8471467760307949
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18408,156,0.82 [0.52-1.30],0.3976390639614355
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18276,24,1.12 [0.46-2.70],0.8048378090833124
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18277,25,0.93 [0.33-2.63],0.8896481141186658
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18690,438,1.08 [0.87-1.34],0.5052835115474279
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18618,366,0.87 [0.65-1.15],0.3246455443978425
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18883,242,1.24 [0.95-1.62],0.1197959735229343
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23561,142,1.43 [1.10-1.87],0.0083803840860923
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23456,37,1.76 [1.22-2.53],0.0023825091483871
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21349,44,0.92 [0.41-2.06],0.8350827354194459
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21502,197,0.94 [0.64-1.38],0.7621002391866831
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22097,792,1.09 [0.92-1.28],0.3293136398913402
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21428,123,1.15 [0.76-1.72],0.5075051582962913
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21353,48,0.65 [0.24-1.73],0.3898148351191491
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21970,665,1.12 [0.94-1.33],0.2179931841835697
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21353,48,1.12 [0.58-2.14],0.7414746040411074
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21532,227,1.11 [0.83-1.49],0.4724275410848139
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21405,100,0.84 [0.48-1.48],0.5541455219189204
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21365,60,0.84 [0.40-1.75],0.6353379849715118
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21429,124,1.34 [0.98-1.83],0.0667160536253301
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21363,58,1.23 [0.75-2.03],0.406839231723973
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21589,284,1.16 [0.90-1.49],0.2636571127907434
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21092,247,0.97 [0.70-1.35],0.8682534609611021
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20892,47,0.83 [0.36-1.91],0.6595290364542521
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20888,43,0.83 [0.34-2.02],0.6821831020245606
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20948,103,0.84 [0.47-1.48],0.5352943249918507
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20896,51,1.09 [0.58-2.05],0.7840936159779353
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20901,56,0.75 [0.33-1.71],0.4924236789862687
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20887,42,0.89 [0.38-2.07],0.7799577649753429
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21030,185,0.80 [0.51-1.24],0.3182164724317018
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20889,44,0.56 [0.19-1.65],0.2941539492754625
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20886,41,1.07 [0.51-2.25],0.8490711630148694
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20939,94,0.60 [0.29-1.23],0.1627946940230779
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20908,63,0.78 [0.37-1.66],0.5199924444353747
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21226,381,1.04 [0.81-1.34],0.7553262526199742
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20976,131,1.05 [0.69-1.59],0.836582513945174
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21041,196,1.19 [0.88-1.61],0.2466853120558566
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22699,87,1.37 [0.93-2.03],0.1103268758467297
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22900,288,1.11 [0.85-1.46],0.4342773158264845
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22658,46,0.93 [0.42-2.04],0.8497539388823983
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22668,56,0.64 [0.26-1.55],0.3217468793603879
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22712,100,0.87 [0.49-1.52],0.6141944629857461
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20239,3770,1.13 [1.04-1.23],0.0044009657757891
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9693,342,0.99 [0.75-1.32],0.9657529458944448
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22632,157,1.66 [1.33-2.07],5.642022007441065e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22519,44,1.56 [0.98-2.47],0.0601312920853891
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22778,33,1.31 [0.66-2.59],0.4434101511973951
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22774,29,2.50 [1.90-3.29],5.756437568983827e-11
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22782,37,1.92 [1.36-2.70],0.0001752351421309
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23607,201,1.09 [0.79-1.50],0.6069360136842897
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23664,47,1.23 [0.69-2.21],0.4796167944250349
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23544,138,0.98 [0.64-1.51],0.942882694488944
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23490,84,1.18 [0.75-1.86],0.4626047531669152
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22602,753,1.01 [0.84-1.21],0.9033158443796574
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cystitis,21918,69,0.79 [0.38-1.62],0.5213052467663004
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21905,56,1.33 [0.82-2.16],0.2477839385095261
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21999,150,1.25 [0.90-1.74],0.1742293307742672
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21932,83,1.05 [0.62-1.77],0.8540441181899963
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22375,526,1.07 [0.87-1.32],0.5049946128684181
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9410,59,0.61 [0.24-1.52],0.2896256840158535
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9383,32,0.71 [0.22-2.22],0.5510609976377765
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydrocele,9385,34,1.33 [0.71-2.48],0.376688466362308
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9422,71,1.04 [0.58-1.86],0.8922925635131582
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9408,57,0.62 [0.25-1.53],0.2955103091818744
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9433,82,1.17 [0.72-1.91],0.5295635975902128
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13067,217,1.05 [0.77-1.43],0.7600800115545838
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12917,67,1.18 [0.73-1.91],0.4869727498258569
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,12922,72,1.10 [0.66-1.82],0.7202974132984579
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12896,46,1.15 [0.63-2.08],0.6562559848597929
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13034,332,1.06 [0.83-1.36],0.644375800046691
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12773,71,1.04 [0.61-1.79],0.8804865072025281
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12869,167,1.12 [0.82-1.55],0.473433603273332
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12018,2380,1.17 [1.06-1.29],0.0019480180464436
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Endometriosis,9888,250,1.31 [1.05-1.63],0.0155331170201315
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9716,78,1.20 [0.79-1.83],0.3850229024403484
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9738,100,1.33 [0.96-1.84],0.0835925812185185
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9905,267,1.09 [0.83-1.44],0.5206494216078589
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9903,265,1.22 [0.96-1.54],0.0979210097523198
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10051,413,1.20 [0.99-1.46],0.0680428070941959
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9783,145,1.15 [0.82-1.62],0.4083001324240346
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9822,184,1.30 [1.01-1.68],0.042118009733155
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9709,71,0.91 [0.49-1.69],0.7618282170984773
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9761,123,1.26 [0.91-1.73],0.1615358597307655
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13199,171,1.24 [0.93-1.64],0.1393771435101678
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13206,165,1.23 [0.92-1.64],0.1661170450474287
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13222,97,0.97 [0.59-1.59],0.8995292244498723
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13216,104,1.00 [0.63-1.59],0.986944545539529
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9697,59,1.51 [1.07-2.13],0.0193714814083036
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9692,54,0.81 [0.36-1.80],0.6008003547957361
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9697,59,1.37 [0.91-2.05],0.1340848033080336
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Irregular menses,13134,324,1.07 [0.83-1.37],0.6126197094457174
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10622,984,1.14 [0.98-1.31],0.0812142532062562
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10316,678,1.14 [0.96-1.35],0.1254363231383048
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13206,139,1.20 [0.87-1.67],0.2652888885564988
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9943,305,0.97 [0.73-1.30],0.8571224935194426
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9866,228,1.23 [0.96-1.57],0.0954484337656061
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9860,222,1.20 [0.91-1.59],0.1848772285436848
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Female infertility,9723,85,1.03 [0.61-1.72],0.9199384391608156
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9716,78,1.07 [0.64-1.78],0.7953326803011075
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13214,713,0.88 [0.71-1.09],0.2347781865101343
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13221,975,0.80 [0.65-0.98],0.0330894350905498
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13213,377,0.88 [0.66-1.18],0.397170621549954
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,12944,108,0.90 [0.54-1.50],0.6869618002381637
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,12989,153,0.68 [0.40-1.15],0.1479696704749655
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,12969,133,1.23 [0.88-1.70],0.2264602739580837
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13229,135,1.01 [0.67-1.54],0.950781633092682
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13231,133,1.00 [0.65-1.53],0.9846007568537268
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13229,345,1.09 [0.85-1.41],0.4920281835390246
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,12987,103,1.09 [0.69-1.73],0.715575160182748
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13076,192,1.08 [0.76-1.51],0.6751334922227612
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12618,117,0.97 [0.61-1.55],0.9076471167837904
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12668,167,0.77 [0.48-1.24],0.2828333438730456
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12698,197,0.74 [0.47-1.16],0.1859381962308709
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12621,120,0.98 [0.63-1.53],0.9192188074145796
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,12613,112,1.18 [0.82-1.69],0.3694106734848029
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12623,122,0.83 [0.50-1.39],0.4877298370344806
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12431,185,0.76 [0.48-1.19],0.2282658545315308
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12602,356,0.72 [0.51-1.01],0.0589949310557013
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,12791,545,0.94 [0.74-1.19],0.6022434956236609
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13236,141,0.74 [0.43-1.25],0.2556559925791241
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,12044,107,0.51 [0.25-1.06],0.0704873349609152
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12328,82,1.10 [0.69-1.74],0.6895413596770918
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13240,279,0.68 [0.46-1.01],0.0561434170706758
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13177,216,0.69 [0.44-1.08],0.1059460183068627
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13229,207,0.95 [0.66-1.37],0.7919844792151137
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13219,197,0.90 [0.61-1.33],0.5929889478849835
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23698,31,1.09 [0.48-2.48],0.8407960858429616
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22492,443,1.01 [0.80-1.28],0.9083469508325868
